AgeX Therapeutics, Inc. Business Finance Contracts & Agreements

52 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Stock Option Agreement
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Serina Therapeutics, Inc. 2017 Stock Option Plan
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Asset Contribution Agreement dated March 26, 2024 between AgeX Therapeutics, Inc. and UniverXome Bioengineering, Inc
Contribution Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Agreement with respect to Convertible Notes dated March 26, 2024, among AgeX Therapeutics, Inc., UniverXome Bioengineering, Inc., the Subsidiary Obligors and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Allonge and Seventh Amendment to Amended and Restated Convertible Promissory Notes dated March 26, 2024, among AgeX Therapeutics, Inc., the Guarantors party thereto and...
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Warrant Agreement, dated March 19, 2024 between AgeX Therapeutics, Inc. and Equinity Trust Company, LLC
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Form of Post-Merger Warrant included in Warrant Agreement dated March 19, 2024
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Sixth Amendment to Amended and Restated Convertible Promissory Note, dated February 9, 2024, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and...
Joinder Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited
Guaranty Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Form of Pledge Agreement by AgeX Therapeutics, Inc
Pledge Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and...
Joinder Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited
Guaranty Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Form of Pledge Agreement by AgeX Therapeutics, Inc
Pledge Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amended and Restated Certificate of Designation of Series B Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Amended and Restated Certificate of Designation of Series A Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Amendment to Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Fourth Amendment to Amended and Restated Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated July 21, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2023
Exchange Agreement, dated July 21, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Exchange Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Form of Certificate of Designation of Series B Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Form of Certificate of Designation of Series A Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to Amended and Restated Secured Convertible Promissory Note, dated June 2, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Allonge and Second Amendment to Amended and Restated Convertible Promissory Note dated May 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to that certain Secured Convertible Facility Agreement, dated March 30, 2020, by and between AgeX Therapeutics, Inc. and Juvenescence Limited
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Subordination Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc., Serina Therapeutics, Inc. and the other investors signatory thereto
Subordination Agreement
AgeX Therapeutics, Inc.
Biotechnology
WA
2023
Convertible Promissory Note, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Convertible Note Purchase Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Amended and Restated Security Agreement, dated March 13, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Security Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Secured Convertible Promissory Note dated March 13, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amended and Restated Secured Convertible Promissory Note, dated February 9, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amendment No. 3 to Registration Rights Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2022
Warrant Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2022
Security Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Security Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2022
Secured Note dated February 14, 2022, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2022
Form of Warrant
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
2022
Amendment No. 2 to Loan Facility Agreement, dated November 8, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
Loan Agreements
AgeX Therapeutics, Inc.
Biotechnology
2021
Amendment No. 2 to Registration Rights Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2021